Selected research
Market Outlook & Growth Opportunities
Global AI Image-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026
Market perspective
The global AI Image-assisted Diagnosis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for AI Image-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Image-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Image-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the AI Image-assisted Diagnosis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the AI Image-assisted Diagnosis Software market include KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO), Solvision, IBM Watson, Butterfly Network, Arterys, Zebra Medical Vision, Freenome, MIT Technology Review and Lunit, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global AI Image-assisted Diagnosis Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Image-assisted Diagnosis Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Image-assisted Diagnosis Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Image-assisted Diagnosis Software market.
AI Image-assisted Diagnosis Software Segment by Company
KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
Solvision
IBM Watson
Butterfly Network
Arterys
Zebra Medical Vision
Freenome
MIT Technology Review
Lunit
DiA Imaging
RetinAi
Subtle Medical
BrainMiner
AI Image-assisted Diagnosis Software Segment by Type
Ultrasound Image
Radiographic Image
Radiation Therapy
Pathological Analysis
Endoscopic Image
AI Image-assisted Diagnosis Software Segment by Application
Hospital
Ambulatory Surgery Center
AI Image-assisted Diagnosis Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global AI Image-assisted Diagnosis Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the AI Image-assisted Diagnosis Software key companies, revenue, market share, and recent developments.
3. To split the AI Image-assisted Diagnosis Software breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions AI Image-assisted Diagnosis Software market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify AI Image-assisted Diagnosis Software significant trends, drivers, influence factors in global and regions.
6. To analyze AI Image-assisted Diagnosis Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Image-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Image-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Image-assisted Diagnosis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Image-assisted Diagnosis Software industry.
Chapter 3: Detailed analysis of AI Image-assisted Diagnosis Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of AI Image-assisted Diagnosis Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of AI Image-assisted Diagnosis Software in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Ultrasound Image
- Radiographic Image
- Radiation Therapy
- Pathological Analysis
- Endoscopic Image
Applications
- Hospital
- Ambulatory Surgery Center
Companies covered
- KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
- Solvision
- IBM Watson
- Butterfly Network
- Arterys
- Zebra Medical Vision
- Freenome
- MIT Technology Review
- Lunit
- DiA Imaging
- RetinAi
- Subtle Medical
- BrainMiner
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global AI Image-assisted Diagnosis Software Market Size, 2021 VS 2025 VS 2032
- 1.3 Global AI Image-assisted Diagnosis Software Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI Image-assisted Diagnosis Software Market Dynamics
- 2.1 AI Image-assisted Diagnosis Software Industry Trends
- 2.2 AI Image-assisted Diagnosis Software Industry Drivers
- 2.3 AI Image-assisted Diagnosis Software Industry Opportunities and Challenges
- 2.4 AI Image-assisted Diagnosis Software Industry Restraints
3 AI Image-assisted Diagnosis Software Market by Company
- 3.1 Global AI Image-assisted Diagnosis Software Company Revenue Ranking in 2025
- 3.2 Global AI Image-assisted Diagnosis Software Revenue by Company (2021-2026)
- 3.3 Global AI Image-assisted Diagnosis Software Company Ranking (2024-2026)
- 3.4 Global AI Image-assisted Diagnosis Software Company Manufacturing Base and Headquarters
- 3.5 Global AI Image-assisted Diagnosis Software Company Product Type and Application
- 3.6 Global AI Image-assisted Diagnosis Software Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global AI Image-assisted Diagnosis Software Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 AI Image-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 AI Image-assisted Diagnosis Software Market by Type
- 4.1 AI Image-assisted Diagnosis Software Type Introduction
- 4.1.1 Ultrasound Image
- 4.1.2 Radiographic Image
- 4.1.3 Radiation Therapy
- 4.1.4 Pathological Analysis
- 4.1.5 Endoscopic Image
- 4.2 Global AI Image-assisted Diagnosis Software Sales Value by Type
- 4.2.1 Global AI Image-assisted Diagnosis Software Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global AI Image-assisted Diagnosis Software Sales Value by Type (2021-2032)
- 4.2.3 Global AI Image-assisted Diagnosis Software Sales Value Share by Type (2021-2032)
5 AI Image-assisted Diagnosis Software Market by Application
- 5.1 AI Image-assisted Diagnosis Software Application Introduction
- 5.1.1 Hospital
- 5.1.2 Ambulatory Surgery Center
- 5.2 Global AI Image-assisted Diagnosis Software Sales Value by Application
- 5.2.1 Global AI Image-assisted Diagnosis Software Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global AI Image-assisted Diagnosis Software Sales Value by Application (2021-2032)
- 5.2.3 Global AI Image-assisted Diagnosis Software Sales Value Share by Application (2021-2032)
6 AI Image-assisted Diagnosis Software Regional Value Analysis
- 6.1 Global AI Image-assisted Diagnosis Software Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global AI Image-assisted Diagnosis Software Sales Value by Region (2021-2032)
- 6.2.1 Global AI Image-assisted Diagnosis Software Sales Value by Region: 2021-2026
- 6.2.2 Global AI Image-assisted Diagnosis Software Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America AI Image-assisted Diagnosis Software Sales Value (2021-2032)
- 6.3.2 North America AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe AI Image-assisted Diagnosis Software Sales Value (2021-2032)
- 6.4.2 Europe AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific AI Image-assisted Diagnosis Software Sales Value (2021-2032)
- 6.5.2 Asia-Pacific AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America AI Image-assisted Diagnosis Software Sales Value (2021-2032)
- 6.6.2 South America AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa AI Image-assisted Diagnosis Software Sales Value (2021-2032)
- 6.7.2 Middle East & Africa AI Image-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
7 AI Image-assisted Diagnosis Software Country-level Value Analysis
- 7.1 Global AI Image-assisted Diagnosis Software Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global AI Image-assisted Diagnosis Software Sales Value by Country (2021-2032)
- 7.2.1 Global AI Image-assisted Diagnosis Software Sales Value by Country (2021-2026)
- 7.2.2 Global AI Image-assisted Diagnosis Software Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.3.2 USA AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.7.2 France AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.14.2 China AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.17.2 India AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt AI Image-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt AI Image-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt AI Image-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
- 8.1.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Information
- 8.1.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Business Overview
- 8.1.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.1.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) AI Image-assisted Diagnosis Software Product Portfolio
- 8.1.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments
- 8.2 Solvision
- 8.2.1 Solvision Company Information
- 8.2.2 Solvision Business Overview
- 8.2.3 Solvision AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.2.4 Solvision AI Image-assisted Diagnosis Software Product Portfolio
- 8.2.5 Solvision Recent Developments
- 8.3 IBM Watson
- 8.3.1 IBM Watson Company Information
- 8.3.2 IBM Watson Business Overview
- 8.3.3 IBM Watson AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.3.4 IBM Watson AI Image-assisted Diagnosis Software Product Portfolio
- 8.3.5 IBM Watson Recent Developments
- 8.4 Butterfly Network
- 8.4.1 Butterfly Network Company Information
- 8.4.2 Butterfly Network Business Overview
- 8.4.3 Butterfly Network AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.4.4 Butterfly Network AI Image-assisted Diagnosis Software Product Portfolio
- 8.4.5 Butterfly Network Recent Developments
- 8.5 Arterys
- 8.5.1 Arterys Company Information
- 8.5.2 Arterys Business Overview
- 8.5.3 Arterys AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.5.4 Arterys AI Image-assisted Diagnosis Software Product Portfolio
- 8.5.5 Arterys Recent Developments
- 8.6 Zebra Medical Vision
- 8.6.1 Zebra Medical Vision Company Information
- 8.6.2 Zebra Medical Vision Business Overview
- 8.6.3 Zebra Medical Vision AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.6.4 Zebra Medical Vision AI Image-assisted Diagnosis Software Product Portfolio
- 8.6.5 Zebra Medical Vision Recent Developments
- 8.7 Freenome
- 8.7.1 Freenome Company Information
- 8.7.2 Freenome Business Overview
- 8.7.3 Freenome AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.7.4 Freenome AI Image-assisted Diagnosis Software Product Portfolio
- 8.7.5 Freenome Recent Developments
- 8.8 MIT Technology Review
- 8.8.1 MIT Technology Review Company Information
- 8.8.2 MIT Technology Review Business Overview
- 8.8.3 MIT Technology Review AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.8.4 MIT Technology Review AI Image-assisted Diagnosis Software Product Portfolio
- 8.8.5 MIT Technology Review Recent Developments
- 8.9 Lunit
- 8.9.1 Lunit Company Information
- 8.9.2 Lunit Business Overview
- 8.9.3 Lunit AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.9.4 Lunit AI Image-assisted Diagnosis Software Product Portfolio
- 8.9.5 Lunit Recent Developments
- 8.10 DiA Imaging
- 8.10.1 DiA Imaging Company Information
- 8.10.2 DiA Imaging Business Overview
- 8.10.3 DiA Imaging AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.10.4 DiA Imaging AI Image-assisted Diagnosis Software Product Portfolio
- 8.10.5 DiA Imaging Recent Developments
- 8.11 RetinAi
- 8.11.1 RetinAi Company Information
- 8.11.2 RetinAi Business Overview
- 8.11.3 RetinAi AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.11.4 RetinAi AI Image-assisted Diagnosis Software Product Portfolio
- 8.11.5 RetinAi Recent Developments
- 8.12 Subtle Medical
- 8.12.1 Subtle Medical Company Information
- 8.12.2 Subtle Medical Business Overview
- 8.12.3 Subtle Medical AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.12.4 Subtle Medical AI Image-assisted Diagnosis Software Product Portfolio
- 8.12.5 Subtle Medical Recent Developments
- 8.13 BrainMiner
- 8.13.1 BrainMiner Company Information
- 8.13.2 BrainMiner Business Overview
- 8.13.3 BrainMiner AI Image-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
- 8.13.4 BrainMiner AI Image-assisted Diagnosis Software Product Portfolio
- 8.13.5 BrainMiner Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst